Xiaoling Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- RNA modifications and cancer 11
- Circular RNAs in diseases 4
- RNA Research and Splicing 4
-
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 6
- Co-authors
- Bhaskara Jasti (4 shared papers)Guiyuan Li (10 shared papers)Zhaoyang Zeng (9 shared papers)Wei Xiong (7 shared papers)Bret Berner (1 shared paper)Amir H. Shojaei (1 shared paper)Bo Xiang (7 shared papers)Ming Zhou (6 shared papers)
- Journals
- Frontiers in Physiology (2 papers)The Journal of Nutritional Biochemistry (1 paper)NeuroMolecular Medicine (1 paper)Molecular Neurobiology (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xiaoling Li
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 528
- Pharmaceutical Science 177
- Molecular Biology 580
- Oncology 97
- Biomaterials 51
Countries citing papers authored by Xiaoling Li
This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).
Fields of papers citing papers by Xiaoling Li
This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 192 | |
| 2 | Design of Controlled Release Drug Delivery Systems | 2005 | 121 |
| 3 | 2019 | 109 | |
| 4 | 2014 | 94 | |
| 5 | 2019 | 90 | |
| 6 | 1998 | 90 | |
| 7 | 2015 | 59 | |
| 8 | 2011 | 53 | |
| 9 | 2018 | 49 | |
| 10 | 2005 | 47 | |
| 11 | 2020 | 34 | |
| 12 | 2021 | 27 | |
| 13 | 2021 | 21 | |
| 14 | 2020 | 16 | |
| 15 | 2017 | 16 | |
| 16 | 2021 | 16 | |
| 17 | 2019 | 16 | |
| 18 | 2021 | 15 | |
| 19 | 2023 | 15 | |
| 20 | 2017 | 14 |
About Xiaoling Li
Xiaoling Li is a scholar working on Molecular Biology, Cancer Research, Pharmaceutical Science, Epidemiology and Surgery, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), RNA modifications and cancer (11 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (4 papers), RNA Research and Splicing (4 papers), Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (2 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Cancer Research (528 citations), Pharmaceutical Science (177 citations), Molecular Biology (580 citations), Oncology (97 citations) and Biomaterials (51 citations). Xiaoling Li has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Bhaskara Jasti, Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Bret Berner, Amir H. Shojaei, Bo Xiang, Ming Zhou, Xiayu Li and Yanhong Zhou. Their work appears in journals such as Frontiers in Physiology, The Journal of Nutritional Biochemistry, NeuroMolecular Medicine, Molecular Neurobiology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.